Matthew Angel - 04 Feb 2026 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role: CEO and President, Director, 10%+ Owner
Signature: /s/ Matthew Angel
Issuer symbol: TPST
Transactions as of: 04 Feb 2026
Net transactions value: $0
Form type: 4
Filing time: 06 Feb 2026, 16:26:13 UTC
Previous filing: 06 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Angel Matthew	CEO and President, Director, 10%+ Owner	C/O TEMPEST THERAPEUTICS, INC., 2000 SIERRA POINT PARKWAY, SUITE 400, BRISBANE	/s/ Matthew Angel	06 Feb 2026	0001931356

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TPST	Employee Stock Option (right to buy)	Award	$0	+269,621		$0.000000	269,621	04 Feb 2026	Common Stock	269,621	$2.38	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option shall vest with respect to 25% of the total number of shares underlying the option on February 4, 2027 and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service.